KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 105 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $6,186,354 | -18.1% | 574,940 | +14.0% | 0.19% | -18.6% |
Q4 2022 | $7,552,811 | +6.5% | 504,193 | -8.7% | 0.23% | -0.4% |
Q3 2022 | $7,092,000 | +74.3% | 552,350 | +31.5% | 0.23% | +66.9% |
Q2 2022 | $4,070,000 | -44.8% | 419,995 | -43.4% | 0.14% | -24.0% |
Q1 2022 | $7,377,000 | +4.5% | 742,158 | +23.8% | 0.18% | +26.2% |
Q4 2021 | $7,056,000 | +52.7% | 599,522 | +47.7% | 0.14% | +64.8% |
Q3 2021 | $4,622,000 | – | 405,834 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 600,000 | $6,456,000 | 0.96% |
SPHERA FUNDS MANAGEMENT LTD. | 450,283 | $4,845,045 | 0.81% |
Rubric Capital Management LP | 2,775,636 | $29,865,843 | 0.77% |
AlphaCentric Advisors LLC | 82,500 | $887,700 | 0.61% |
Parkman Healthcare Partners LLC | 250,257 | $2,692,765 | 0.59% |
Lion Point Capital, LP | 113,540 | $1,221,690 | 0.50% |
RICE HALL JAMES & ASSOCIATES, LLC | 655,656 | $7,054,859 | 0.40% |
Jackson Creek Investment Advisors LLC | 61,599 | $663 | 0.28% |
Tejara Capital Ltd | 48,500 | $521,860 | 0.27% |
Birchview Capital, LP | 30,000 | $323 | 0.25% |